Joshua McFarlane is an Oncology physician affiliated with Virginia Cancer Institute. OpenAlex indexes 11 publications with 437 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
62.6%PD-1 inhibitor45.9%Pembrolizumab60%Nivolumab40%Part B, office-administered≥27 patientsCD38-directed Cytolytic Antibody12.1%Daratumumab100%Part B, office-administered≥13 patients+ 11 more classes in this area
Musculoskeletal
17%RANK Ligand Inhibitor16.8%Denosumab100%Part B, office-administered≥46 patientsBisphosphonate0.2%Zoledronic acid100%Part B, office-administered≥15 patientsBlood & clotting
5.5%Erythropoiesis-stimulating Agent5.1%Epoetin alfa100%Part B, office-administered≥35 patientsFactor Xa inhibitor0.3%Eliquis72%Xarelto28%Part D≥22 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Erin Alesi, MD
Virginia Cancer Institute
Melissa Yacur, MD
Virginia Cancer Institute
Keri Maher, DO
Virginia Cancer Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”